أعرض في EDS

PDB22 EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN IN PATIENTS WITHTYPE 2 DIABETES IN SPAIN AND ITALY

التفاصيل البيبلوغرافية
العنوان:	PDB22 EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN IN PATIENTS WITHTYPE 2 DIABETES IN SPAIN AND ITALY
المؤلفون:	Katrina Erny-Albrecht, C Townsend, R Kotchie, William J. Valentine, S Nielsen, G Goodall
المصدر:	Value in Health. 10(6)
بيانات النشر:	Elsevier BV, 2007.
سنة النشر:	2007
مصطلحات موضوعية:	medicine.medical_specialty, business.industry, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Insulin aspart, Endocrinology, Soluble insulin, Diabetes mellitus, Internal medicine, Medicine, In patient, business, medicine.drug
تدمد:	1098-3015
DOI:	10.1016/s1098-3015(10)64970-4
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ff9925705a084ed27a7be3e52a54a9
حقوق:	OPEN
رقم الأكسشن:	edsair.doi.dedup.....26ff9925705a084ed27a7be3e52a54a9
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	10983015
DOI:	10.1016/s1098-3015(10)64970-4